These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1650110)

  • 21. Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients.
    Kafka MS; Kleinman JE; Karson CN; Wyatt RJ
    Hillside J Clin Psychiatry; 1986; 8(1):15-24. PubMed ID: 3017834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does operational diagnosis of schizophrenia significantly impact intellectual deficits in psychotic disorders?
    Kitamura H; Shioiri T; Itoh M; Sato Y; Shichiri K; Someya T
    J Intellect Disabil Res; 2007 Oct; 51(Pt 10):812-20. PubMed ID: 17803499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H; Ofuji M; Nozaki M; Tsurumi K
    Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inactivation of prostaglandin endoperoxide synthetase from the microsomal fraction of human platelets during the reaction].
    Mevkh AT; Basevich VV; Iarving I; Varfolomeev SD
    Biokhimiia; 1982 Nov; 47(11):1852-8. PubMed ID: 6817828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme immunoassays for cyclooxygenase and 12-lipoxygenase of human platelets.
    Yoshimoto T; Ehara H; Konishi Y; Yokoyama C; Murakami J; Yamamoto S; Hattori A
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():82-5. PubMed ID: 2526567
    [No Abstract]   [Full Text] [Related]  

  • 26. Rumination and negative symptoms in schizophrenia.
    Halari R; Premkumar P; Farquharson L; Fannon D; Kuipers E; Kumari V
    J Nerv Ment Dis; 2009 Sep; 197(9):703-6. PubMed ID: 19752652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Subjective cognitive disorders in schizophrenia].
    Peralta Martín V; Cuesta Zorita MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1993; 21(1):14-20. PubMed ID: 8499035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
    Matsumoto H; Pietruszewska I; Roguska E
    Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
    [No Abstract]   [Full Text] [Related]  

  • 30. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cognitive deficit and schizophrenia].
    Torres A; Méndez L; Olivares JM; Vaamonde A
    Actas Esp Psiquiatr; 2001; 29(1):1-9. PubMed ID: 11333512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic, symptomatic and sanitary assessment of schizophrenic patients in Liege psychiatric institutions].
    Sarto D; Desseilles M; Martin M; Albert A
    Encephale; 2002; 28(5 Pt 1):403-10. PubMed ID: 12386541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affective reactivity of cognitive functioning and family history in schizophrenia.
    Docherty NM; Grosh ES; Wexler BE
    Biol Psychiatry; 1996 Jan; 39(1):59-64. PubMed ID: 8719127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of platelet cyclooxygenase by red cells in vitro.
    Violi F; Ghiselli A; Alessandri C; Frattaroli S; Iuliano L; Balsano F
    N Engl J Med; 1985 Oct; 313(17):1091-2. PubMed ID: 3930963
    [No Abstract]   [Full Text] [Related]  

  • 36. [Negativism in psychiatric patients].
    ACHTE KA
    Nord Psykiatr Tidsskr; 1962; 16():95-9. PubMed ID: 13859153
    [No Abstract]   [Full Text] [Related]  

  • 37. The experience of schizophrenia.
    Coburn DC
    J Psychiatr Nurs Ment Health Serv; 1977 Dec; 15(12):9-13. PubMed ID: 201754
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevated plasma prostaglandin E2 levels in schizophrenia.
    Kaiya H; Uematsu M; Ofuji M; Nishida A; Takeuchi K; Nozaki M; Idaka E
    J Neural Transm; 1989; 77(1):39-46. PubMed ID: 2746199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schizophrenia and aging: no more dearth of data?
    Jeste DV; Nasrallah HA
    Am J Geriatr Psychiatry; 2003; 11(6):584-7. PubMed ID: 14609797
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adenase inhibitor in thrombocytes of healthy humans].
    Sokovnina IaM; Tentsova IA; Debov SS
    Vopr Med Khim; 1977; (3):425-7. PubMed ID: 888412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.